Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Preclinical Probes for Oncology II

  • You have access
    PET imaging of 11C-labeled cyclooxygenase-1 (COX-1) and COX-2 radioligands in ovarian, breast, and pancreatic cancer xenograft mouse models.
    Amanda Boyle, Ian Duffy, Cassis Varlow, Junchao Tong, Sami Zoghbi, Victor Pike, Robert Innis and Neil Vasdev
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 440;
  • You have access
    68Ga-NOTA-MAL-MZHER2 Affibody: A feasible PET tracer for the noninvasive detection of lesions overexpressing HER2 in advanced gastric cancer patients and its utility in monitoring therapeutic response
    Xiaoyi Guo, Nina Zhou, Chang Liu, Yuping Xu, Mi Yang, Hua Zhu, Lin Shen and Zhi Yang
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 442;
  • You have access
    Evaluation of bacteria Nissle 1917 for tumor targeting imaging
    Qingyao Liu and Xiali Lan
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 444;
  • You have access
    Inhibition of 22RV1 growth with miniSOG2 excited by Cerenkov light of 18F-FDG or 68Ga-PSMA617
    Xiang Zhou, Weidong Yang and Jing Wang
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 443;
  • You have access
    Optimizing radiocobalt labeled HER3-targeting affibody molecules for next day PET-imaging of HER3 expression
    Sara Rinne, Charles Dahlsson Leitao, Bogdan Mitran, Vladimir Tolmachev, Stefan Stahl, John Lofblom and Anna Orlova
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 445;
  • You have access
    Imaging PD-L1 expression in tumors following radiotherapy treatment
    Emily Ehlerding, Carolina Ferreira, Dawei Jiang, LEI KANG, Jonathan Engle, Douglas McNeel and Weibo Cai
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 608;
  • You have access
    Novel 64Cu-NOTA-1B50-1 targeting ƒ¿2ƒÂ1for specific cancer stem cell imaging: A preliminary experiments on Hepatocellular Carcinoma
    Xiaoyi Guo, Hua Zhu and Zhi Yang
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 610;
  • You have access
    Concurrent injection of cold antibody allows PET imaging of orthotopic pancreatic tumor with 64Cu-labeled anti-PD-L1
    Xiaoxia Wen, Jun Zhao, Xiaofei Wen, Sixiang Shi, Tingting Li and Chun Li
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 607;
  • You have access
    ImmunoPET imaging of pancreatic cancer with an anti-Trop2 antibody
    Weiyu Chen, Dawei Jiang, Emily Ehlerding, Dalong NI, Tuanwei Sun, Miao Li, Zachary Rosenkrans, Jonathan Engle and Weibo Cai
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 611;
  • You have access
    Immuno-PET imaging of activation markers on antigen-specific CD4 T cells in a mouse model of melanoma
    Simone Krebs, Lukas Carter, Daniel Hirschhorn-Cymerman, Jedd Wolchok, Taha Merghoub, Heiko Schoder and Steven Larson
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 609;

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
SNMMI

© 2025 SNMMI

Powered by HighWire